| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/24/2008 | CN101270110A Novel sulfonyl substituted benzophenone oxide compounds, prepraring method and application thereof |
| 09/24/2008 | CN101269256A Therapy electrode tablet clamping self-pasting medicament film and preparation method thereof |
| 09/24/2008 | CN101269255A Therapy electrode tablet clamping self-pasting medicament film and preparation method thereof |
| 09/24/2008 | CN101269209A Tireballe foreign body prescription |
| 09/24/2008 | CN101269207A Brain tonic hair care formula for anti-drop, generating hair and nourishing hair |
| 09/24/2008 | CN101269194A Medicament tincture for treating scobination type prurigo and preparation method thereof |
| 09/24/2008 | CN101269193A Liquid medicine for treating kakidrosis of feet |
| 09/24/2008 | CN101269190A Blood circulation activating and stasis removing, and Qi-smoothening blood-nourishing medicament combination and preparation method thereof |
| 09/24/2008 | CN101269186A Burn cream |
| 09/24/2008 | CN101269183A Externally applied medicament for treating exogenous injury of athletes |
| 09/24/2008 | CN101269181A Phragmites communis trin kuh-seng soup |
| 09/24/2008 | CN101269176A Quick-effective bones injury medicine |
| 09/24/2008 | CN101269171A Traditional Chinese medicine composition for treating dermatosis, preparation method and uses thereof |
| 09/24/2008 | CN101269163A Medical ointment for treating chronic eczema and preparation method thereof |
| 09/24/2008 | CN101269109A Medicament for treating burn and scald |
| 09/24/2008 | CN101269094A Fruit and/or vegetable derived composition |
| 09/24/2008 | CN101269093A Wall-breaking abstraction melissa powder oil and fat method with supercritical carbonic anhydride |
| 09/24/2008 | CN101269038A Chlorpheniramine maleate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN100420739C Nestin-expressing hair follicle stem cells |
| 09/24/2008 | CN100420680C Extraction and separation method of moleplant seed sterol |
| 09/24/2008 | CN100420460C Chinese medicinal compsns. for treating burn and scald, its prepn. and usage |
| 09/24/2008 | CN100420458C Externally applied Chinese traditional medicine formulation and its preparing method |
| 09/24/2008 | CN100420451C Chinese medicinal preparation for treating alopecia |
| 09/24/2008 | CN100420439C Use of biguanide derivatives for making a medicine having a wound healing effect |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427627 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | CA2582676A1 Building structure and components thereof |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2377544C Hyaluronic acid anti-adhesion barrier |
| 09/23/2008 | CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 09/23/2008 | CA2266479C Vitamin d analogues |
| 09/23/2008 | CA2147302C A lipid composition for normalizing injury |
| 09/21/2008 | CA2637157A1 Mesenchymal stem cells and uses therefor |
| 09/20/2008 | CA2625381A1 Compositions containing retinoid and beta-aminoisobutyic acid derivatives |
| 09/18/2008 | WO2008112940A1 Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
| 09/18/2008 | WO2008111562A1 Whitening agent |
| 09/18/2008 | WO2008111526A1 Method for production of sugar oxazoline derivative |
| 09/18/2008 | WO2008111296A1 Pharmaceutical agent for prevention and treatment of skin disease induced by accelerated keratinization |
| 09/18/2008 | WO2008111271A1 Oral composition for nourishing the hair and stimulating hair growth |
| 09/18/2008 | WO2008111244A1 External preparation for skin, and food |
| 09/18/2008 | WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | WO2008111009A1 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | WO2008110853A1 Topical therapeutic composition of plant origin for the treatment of psoriasis and other dermatological diseases |
| 09/18/2008 | WO2008110826A1 Polyaphron topical composition with a corticosteroid |
| 09/18/2008 | WO2008110819A1 Polyaphron topical composition with vitamin d |
| 09/18/2008 | WO2008110815A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | WO2008110268A1 Cosmetic compositions |
| 09/18/2008 | WO2008084241A3 Use of aminolevulinic acid and derivatives thereof |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227868 Composition Comprising an Hdac Inhibitor in Combination with a Retinoid |
| 09/18/2008 | US20080227861 Inhibition of Allergic Contact Dermatitis By N-L-ALPHA-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 09/18/2008 | US20080227847 (S)-2-hydro-2,6-diaminohexanal-(E)-methoxy-4-oxobut-2-enoate(lysine monomethylfumarate); treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders |
| 09/18/2008 | US20080227842 Non-fluorescent chlorophyll catabolites |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227831 Contains N-methylnicotinamide; seaweed extracts; atherosclerosis |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227759 Topical composition |
| 09/18/2008 | US20080227738 Compositions and methods for cell dedifferentiation and tissue regeneration |
| 09/18/2008 | US20080227725 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080226756 Compositions comprising a c-glycoside compound |
| 09/18/2008 | US20080226751 Wound healing agents; skin ulcers; post-operative trauma or burns; allows passage of nitric oxide to skin; ischaemia, Raynaud's phenomenon |
| 09/18/2008 | US20080226720 Cultured cells having a wound healing phenotype, wherein the cells have higher levels of expression of expression of apolipoprotein D, matrix metalloprotease 2, and collagen 3a1 relative to the expression level of Ribosomal protein L32; chronic open lesions slow or resistant to healing; cell therapy |
| 09/18/2008 | US20080226718 Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases |
| 09/18/2008 | US20080226700 Containing allantoin and plant extracts; skin disorders; antiulcer agents |
| 09/18/2008 | US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders |
| 09/18/2008 | US20080226616 Mixture comprising polyacrylic acid salts, acrylate/C10-30 alkyl acrylate crosspolymer and carrageenan for use as agent which reduces cellulite and skin irregularities |
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226583 Therapeutic polyesters and polyamides |
| 09/18/2008 | US20080226581 Cosmetics, drugs; transfer optical properties; fluorescence, optical brighteners |
| 09/18/2008 | US20080226578 Forming coating on keratin fibers; mixture of two polymers |
| 09/18/2008 | DE102007013366A1 Verwendung von Chroman-4-on-Derivaten The use of chroman-4-one derivatives |
| 09/18/2008 | DE102007011676A1 Preparation of active substances e.g. polyphenol resveratrol, useful e.g. as additives for plant protective agents, comprises extracting the active substances from leafage and rhizome of Fallopia plant named igniscum |
| 09/18/2008 | DE102004045187B4 Wirkstoffe zur Überführung von inaktivem TGFb-latent in aktiven TGFb und deren Verwendung in kosmetischen und pharmazeutischen Zusammensetzungen Agents for the conversion of inactive latent TGFb in active TGFb and their use in cosmetic and pharmaceutical compositions |
| 09/18/2008 | CA2680625A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | CA2680544A1 Skin-whitening agent |
| 09/18/2008 | CA2680483A1 Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same |
| 09/18/2008 | CA2680405A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | CA2679589A1 Method for production of sugar oxazoline derivative |
| 09/17/2008 | EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies |
| 09/17/2008 | EP1970382A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1970076A1 Pharmaceutical composition for application to nail |
| 09/17/2008 | EP1970071A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 09/17/2008 | EP1970049A1 Polyaphron topical composition with vitamin D and corticosteroid |
| 09/17/2008 | EP1970048A1 Polyaphron topical composition with vitamin D |
| 09/17/2008 | EP1970047A1 Polyaphron topical composition with a corticosteroid |
| 09/17/2008 | EP1968961A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2008 | EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |